Scholarlink

Objective <p>The present study aimed examine the relationship between the microRNA gene polymorphisms (MicroRNAs) (MicroRNA-149 (rs2292832), MicroRNA-146a (rs2910164), MicroRNA-196a2 (rs11614913)) with liver cirrhosis (LC) and hepatocellular carcinoma (HCC) risk.</p> Methods <p>To identify relevant case–control studies, we conducted a systematic search across several bibliographic databases, including Science Direct, PubMed, and Embase. The Review Manager (version 5.4) and MetaGenyo (<a href="https://metagenyo.genyo">https://metagenyo.genyo</a>.) were used for the reviews and statistical analysis. The data were collectively analyzed across 29 research articles, comprising 1643 cases and 1424 controls for liver cirrhosis and 9798 cases and 10,205 controls for hepatocellular carcinoma respectively for the present meta-analysis.</p> Results <p>The outcomes of the MicroRNA-196a2 (rs11614913) gene polymorphism for liver cirrhosis (LC) were statistically non-significant in all genetic models. For hepatocellular carcinoma (HCC), the MicroRNA-149 (rs2292832) gene polymorphisms were statistically significant in the allelic, recessive, and dominant models (<i>p</i> &lt; 0.05), but non-significant in the over-dominant model (<i>p</i> &gt; 0.05). Similarly, the MicroRNA-196a2 (rs11614913) gene polymorphism for HCC was statistically significant in the allelic, recessive, and dominant models (<i>p</i> &lt; 0.05), but non-significant in the over-dominant model (<i>p</i> &gt; 0.05). Additionally, the MicroRNA-146a (rs2910164) gene polymorphism for HCC was statistically significant in the allelic, recessive, and over-dominant models (<i>p</i> &lt; 0.05), but non-significant in the dominant model (<i>p</i> &gt; 0.05).</p> Conclusion <p>Results from our meta-analysis suggest that MicroRNA-196a2 (rs11614913) is associated with an increased risk of HCC but not with liver cirrhosis. Notably, the gene polymorphisms MicroRNA-146a (rs2910164) and MicroRNA-149 (rs2292832) were associated with both HCC susceptibility and progression. These findings indicate that these microRNAs could potentially serve as biomarkers for the diagnosis and treatment of HCC.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Evaluation of MicroRNA gene polymorphisms (MicroRNA-149 (rs2292832), MicroRNA-146a (rs2910164), MicroRNA-196a2 (rs11614913)) and its association with liver cirrhosis (LC) and hepatocellular carcinoma (HCC)

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月7日

查看全文
  • Bibin Savio Antony,
  • Subashini T S,
  • Thangam C,
  • Gowtham Kumar Subbaraj

摘要

Objective

The present study aimed examine the relationship between the microRNA gene polymorphisms (MicroRNAs) (MicroRNA-149 (rs2292832), MicroRNA-146a (rs2910164), MicroRNA-196a2 (rs11614913)) with liver cirrhosis (LC) and hepatocellular carcinoma (HCC) risk.

Methods

To identify relevant case–control studies, we conducted a systematic search across several bibliographic databases, including Science Direct, PubMed, and Embase. The Review Manager (version 5.4) and MetaGenyo (https://metagenyo.genyo.) were used for the reviews and statistical analysis. The data were collectively analyzed across 29 research articles, comprising 1643 cases and 1424 controls for liver cirrhosis and 9798 cases and 10,205 controls for hepatocellular carcinoma respectively for the present meta-analysis.

Results

The outcomes of the MicroRNA-196a2 (rs11614913) gene polymorphism for liver cirrhosis (LC) were statistically non-significant in all genetic models. For hepatocellular carcinoma (HCC), the MicroRNA-149 (rs2292832) gene polymorphisms were statistically significant in the allelic, recessive, and dominant models (p < 0.05), but non-significant in the over-dominant model (p > 0.05). Similarly, the MicroRNA-196a2 (rs11614913) gene polymorphism for HCC was statistically significant in the allelic, recessive, and dominant models (p < 0.05), but non-significant in the over-dominant model (p > 0.05). Additionally, the MicroRNA-146a (rs2910164) gene polymorphism for HCC was statistically significant in the allelic, recessive, and over-dominant models (p < 0.05), but non-significant in the dominant model (p > 0.05).

Conclusion

Results from our meta-analysis suggest that MicroRNA-196a2 (rs11614913) is associated with an increased risk of HCC but not with liver cirrhosis. Notably, the gene polymorphisms MicroRNA-146a (rs2910164) and MicroRNA-149 (rs2292832) were associated with both HCC susceptibility and progression. These findings indicate that these microRNAs could potentially serve as biomarkers for the diagnosis and treatment of HCC.